180 related articles for article (PubMed ID: 34387090)
1. Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
Paul S; Wong M; Akhabue E; Mehta RC; Kramer H; Isakova T; Carnethon MR; Wolf M; Gutiérrez OM
J Am Heart Assoc; 2021 Aug; 10(16):e020196. PubMed ID: 34387090
[TBL] [Abstract][Full Text] [Related]
2. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
Emrich IE; Brandenburg V; Sellier AB; Schauerte J; Wiedenroth J; Untersteller K; Lennartz CS; Seiler-Mussler S; Wagenpfeil S; Fliser D; Heine GH
Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients.
Gao S; Xu J; Zhang S; Jin J
Blood Purif; 2019; 47 Suppl 1(Suppl 1):24-30. PubMed ID: 30699419
[TBL] [Abstract][Full Text] [Related]
4. C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival.
Chu C; Elitok S; Zeng S; Xiong Y; Hocher CF; Hasan AA; Krämer BK; Hocher B
BMC Nephrol; 2021 Apr; 22(1):125. PubMed ID: 33832449
[TBL] [Abstract][Full Text] [Related]
5. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
[TBL] [Abstract][Full Text] [Related]
6. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
[TBL] [Abstract][Full Text] [Related]
7. C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.
Eisenga MF; van Londen M; Leaf DE; Nolte IM; Navis G; Bakker SJL; de Borst MH; Gaillard CAJM
J Am Soc Nephrol; 2017 Dec; 28(12):3639-3646. PubMed ID: 28774998
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
[TBL] [Abstract][Full Text] [Related]
9. Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.
Haring R; Enserro D; Xanthakis V; Mitchell GF; Benjamin EJ; Hamburg NM; Sullivan L; Nauck M; Wallaschofski H; Vasan RS
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27385427
[TBL] [Abstract][Full Text] [Related]
10. FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study.
Akhabue E; Montag S; Reis JP; Pool LR; Mehta R; Yancy CW; Zhao L; Wolf M; Gutierrez OM; Carnethon MR; Isakova T
Hypertension; 2018 Jul; 72(1):70-76. PubMed ID: 29712737
[TBL] [Abstract][Full Text] [Related]
11. Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.
Sharma S; Katz R; Ginsberg C; Bullen A; Vallon V; Thomson S; Moe OW; Hoofnagle AN; de Leeuw PW; Kroon AA; Houben AJHM; Ix JH
J Bone Miner Res; 2022 Jun; 37(6):1170-1178. PubMed ID: 35373859
[TBL] [Abstract][Full Text] [Related]
12. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial.
Stöhr R; Brandenburg VM; Heine GH; Maeder MT; Leibundgut G; Schuh A; Jeker U; Pfisterer M; Sanders-van Wijk S; Brunner-la Rocca HP
Eur J Heart Fail; 2020 Apr; 22(4):701-709. PubMed ID: 32020782
[TBL] [Abstract][Full Text] [Related]
13. Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos.
Mehta R; Cai X; Hodakowski A; Thyagarajan B; Zeng D; Zee PC; Wohlgemuth WK; Redline S; Lash JP; Wolf M; Isakova T
Bone; 2018 Sep; 114():278-284. PubMed ID: 29986841
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.
Garimella PS; Ix JH; Katz R; Chonchol MB; Kestenbaum BR; de Boer IH; Siscovick DS; Shastri S; Hiramoto JS; Shlipak MG; Sarnak MJ
Atherosclerosis; 2014 Mar; 233(1):91-6. PubMed ID: 24529128
[TBL] [Abstract][Full Text] [Related]
15. Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.
Christodoulou M; Aspray TJ; Piec I; Fraser WD; Schoenmakers I;
Age Ageing; 2024 May; 53(5):. PubMed ID: 38770543
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
[TBL] [Abstract][Full Text] [Related]
17. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
18. Fatty Acid Binding Protein-4 and Risk of Cardiovascular Disease: The Cardiovascular Health Study.
Egbuche O; Biggs ML; Ix JH; Kizer JR; Lyles MF; Siscovick DS; Djoussé L; Mukamal KJ
J Am Heart Assoc; 2020 Apr; 9(7):e014070. PubMed ID: 32248728
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).
Westerberg PA; Tivesten Å; Karlsson MK; Mellström D; Orwoll E; Ohlsson C; Larsson TE; Linde T; Ljunggren Ö
BMC Nephrol; 2013 Apr; 14():85. PubMed ID: 23587028
[TBL] [Abstract][Full Text] [Related]
20. Biological variability of plasma intact and C-terminal FGF23 measurements.
Smith ER; Cai MM; McMahon LP; Holt SG
J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]